Lower-Intensity Warfarin May be Safe with Surgical Mechanical Valve
(MedPage Today) -- Fewer bleeds with lower target INR, but dual antiplatelet therapy still a no-go (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 11, 2018 Category: Cardiology Source Type: news
Lower-Intensity Warfarin May be Safe with Surgical Mechanical Valve Designed for It
(MedPage Today) -- Fewer bleeds with lower target INR, but dual antiplatelet therapy still a no-go (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - June 11, 2018 Category: Surgery Source Type: news
Roche launches CoaguCheck Vantus blood coagulation monitor
Roche (OTC:RHHBY) said today it is launching its CoaguCheck Vantus system designed for monitoring blood coagulation, specifically for patients on warfarin therapy.
The Switzerland-based company said the CoaguCheck Vantus features built in Bluetooth technology to allow patients to use their smart devices and a compatible application to send results of the coagulation testing to their healthcare providers to reduce lab visits.
Roche touted that the system can improve patient engagement and compliance, as well as establishing a better connection between patients and their doctors.
“As healthcare systems face continued ...
Source: Mass Device - June 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Patient Monitoring Roche Source Type: news
Roche launches CoaguChek Vantus to monitor coagulation levels wirelessly
As Pharma giant Roche continues its dive into the digital health realm, it is releasing a new self-testing device for INR or blood coagulation levels, that can wirelessly connect to a smartphone app. The CoaguChek Vantus system, which is designed for Warfarin patients to monitor their coagulation levels, includes built in Bluetooth technology. (Source: mobihealthnews)
Source: mobihealthnews - June 11, 2018 Category: Information Technology Source Type: news
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
CoaguChek® Vantus system enables wireless reporting of INR results, making it easier for patients to accurately report their results
INDIANAPOLIS, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announc... Devices, Monitoring, Product Launch Roche Group, CoaguChek, Vantus, coagulation, Warfarin, coumadin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news
New Real-World Study Finds Long-Term XARELTO ® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli Compared to Warfarin in Frail Patients with Non-Valvular Atrial Fibrillation
(Source: Johnson and Johnson)
Source: Johnson and Johnson - May 24, 2018 Category: Pharmaceuticals Source Type: news
Warfarin Class Tied to Higher Death Rate in COPD
(MedPage Today) -- Retrospective results shouldn ' t change practice, but deserve more study (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2018 Category: Allergy & Immunology Source Type: news
Extended INR Test Intervals Safe for Warfarin-Treated Patients
WEDNESDAY, May 23, 2018 -- For stable warfarin-treated patients, extended international normalized ratio (INR) testing can be successfully and safely implemented, according to a study published online May 15 in the Journal of Thrombosis and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2018 Category: Pharmaceuticals Source Type: news
Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis - Lombardo S, Millar D, Jurkovich GJ, Coimbra R, Nirula R.
BACKGROUND: Recombinant factor VIIa (rFVIIa) has been used off-label as an adjunct in the reversal of warfarin therapy and management of hemorrhage after trauma. Only a handful of these reports are rigorous studies, from which results regarding safety and ... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Poor NOAC Adherence in AF Wreaks Havoc on Efficacy vs Warfarin Poor NOAC Adherence in AF Wreaks Havoc on Efficacy vs Warfarin
Benefits of novel oral anticoagulants that wowed in clinical trials may not carry over into clinical practice, when adherence to prescribed therapy usually declines, suggests an observational analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Low NOAC Adherence Worse Than Taking Warfarin?
(MedPage Today) -- Higher thromboembolic risk seen in observational data (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 14, 2018 Category: Cardiology Source Type: news
Blood Pressure Management Goals in Stroke Care
Blood pressure management goals in stroke care
You arrive at a small rural emergency healthcare facility to transport a 72-year-old female who presents to the ED with the worst headache of her life. She’s to be transported to a tertiary center with neurosurgical services.
Upon further questioning you determine her headache was sudden onset with maximum intensity.
When reviewing her history and medications, you note that she’s currently on Coumadin (warfarin) with an international normalized ratio (INR) of 3.5, with the following vital signs noted on the monitor upon entering the room: blood pressure of 209/75 mmHg; hea...
Source: JEMS Patient Care - May 1, 2018 Category: Emergency Medicine Authors: Ken Davis, BA, EMT-P, FP-C Tags: Patient Care Cardiac & Resuscitation Source Type: news
Five Things Surgeons Need to Know About NOACs to Minimize Risks Five Things Surgeons Need to Know About NOACs to Minimize Risks
Non-vitamin K oral anticoagulants (NOACs) differ in important ways from warfarin, and surgeons need to appreciate these differences, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2018 Category: Consumer Health News Tags: General Surgery News Source Type: news
Continuous Apixaban Safe During AF Ablation in At-Risk Patients Continuous Apixaban Safe During AF Ablation in At-Risk Patients
AXAFA-AFNEX 5 trial is the fourth to show similar safety with a novel oral anticoagulant vs warfarin, but some are disappointed with the new data.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 26, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
